CBU
IDXX icon

CIBC Bancorp USA’s Idexx Laboratories IDXX Stock Holding History

CIBC Bancorp USA’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183M Sell
346,891
-20,611
-6% -$11.6M 0.22% 112
2026
Q1 		$207M Buy
+367,502
New +$236M 0.28% 92
2025
Q3 		$8.93M Buy
+13,983
New +$8.49M 0.05% 279

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

CIBC Bancorp USA's IDXX Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Idexx Laboratories (IDXX) stake by 5.6% in Q2 2026, selling an estimated $11.6M and leaving 346,891 shares worth $183M. The position accounts for 0.22% of the portfolio, ranked #112.

CIBC Bancorp USA first reported a position in IDXX in Q3 2025 and has held it in 3 quarters since. The position peaked at $207M in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • CIBC Bancorp USA held 346,891 shares of Idexx Laboratories worth $183M as of Q2 2026.
  • CIBC Bancorp USA sold 20,611 Idexx Laboratories shares in Q2 2026, an estimated $11.6M.
  • Idexx Laboratories made up 0.22% of CIBC Bancorp USA's portfolio in Q2 2026, its #112 holding.
  • CIBC Bancorp USA first reported a position in Idexx Laboratories in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Idexx Laboratories position peaked at $207M in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.